Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of cdr1as in prenatal screening for neural tube defects, products and methods for prenatal screening for neural tube defects

A neural tube defect and prenatal screening technology, applied in the field of clinical diagnosis, can solve problems such as inability to diagnose, and achieve the effects of low professional requirements, wide universality, and sensitive and fast detection cost.

Active Publication Date: 2022-05-24
GUANGZHOU WOMEN AND CHILDRENS MEDICAL CENTER
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, on the one hand, this technique is too dependent on the operator's skill, and on the other hand, it cannot be distinguished before obvious morphological changes occur, so it cannot be diagnosed in early pregnancy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of cdr1as in prenatal screening for neural tube defects, products and methods for prenatal screening for neural tube defects
  • Application of cdr1as in prenatal screening for neural tube defects, products and methods for prenatal screening for neural tube defects
  • Application of cdr1as in prenatal screening for neural tube defects, products and methods for prenatal screening for neural tube defects

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1 Screening of Markers

[0052] Neural tube tissue samples from 10 groups of children with NTDs (experimental samples) and 10 groups of normal fresh neural tube tissue samples (control samples) of similar age were collected. The circular RNA chip was sequenced, and microarray analysis was performed to select the five circular RNAs with the largest fold difference, including circRNA-CDR1as, Circ-TTBL C2, Circ-MYLK, CZNF292 and CircRNA100876.

[0053] For the test samples and control samples, the extracted total RNA was reverse-transcribed with random primers of the reverse transcription kit, circRNA-CDR1as primers were designed, and the expression levels of CDR1as in the test samples and control samples were detected by RT-PCR. The extent to which CDR1as was elevated in the test samples. The result is as figure 1 Among them, the expression difference of circRNA-CDR1as was the most significant.

[0054] Among them, the circRNA-CDR1as primers are as follows:

...

Embodiment 2

[0059] Example 2 The effect of circRNA-CDR1as on cell proliferation

[0060]Plasmids expressing circRNA-CDR1as were constructed using pcDNA3.1, embryonic stem cells were transiently transfected with lipo2000, and then induced with 5uM RA to successfully induce differentiation into neural stem cells to construct neural stem cells overexpressing circRNA-CDR1as. The neural stem cells after induction and differentiation were subjected to the following experiments: incubate the neural stem cells with CCK8, detect the absorbance at 450 nm of the cells on the 1st, 2nd, 3rd, 4th, 5th, and 6th days, respectively, and do the cell proliferation and growth curves to reflect the proliferation. The result is as figure 2 As shown, neural stem cells overexpressed by circRNA-CDR1as proliferated faster than those in which pcDNA3.1 plasmid was empty, indicating that circRNA-CDR1as could promote cell proliferation.

[0061] The siRNA of circRNA-CDR1as was designed and purchased from Ribo Biotec...

Embodiment 3

[0063] Example 3 The effect of circRNA-CDR1as on the expression level of TRIM-71

[0064] Referring to the experiment in Example 2, circRNA-CDR1as-overexpressing neural stem cells and idling pcDNA3.1 plasmid neural stem cells were obtained, and the above two cells were cultured with or without cycloheximide (Dactinomycin) medium, respectively. The total protein in the cells was extracted by the whole protein extraction kit. After the protein concentration was determined by the BCA protein concentration assay kit, each group was diluted to the same concentration and added to the loading buffer for denaturation, and detected by western blot. In the experiment, GAPDH was used as the internal reference. The differences in the expression of TRIM-71 in cells were compared. The result is as Figure 4 As shown, the protein amount of TRIM71 in neural stem cells overexpressed by circRNA-CDR1as is less than that in neural stem cells with empty pcDNA3.1 plasmid. expression.

[0065] Re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an application of CDR1as in the prenatal screening of neural tube defects, a product and a method of prenatal screening of neural tube defects, and relates to the technical field of clinical diagnosis, including providing circRNA-CDR1as in prenatal screening of neural tube defects Application of screening markers. Studies have found that circRNA-CDR1as is significantly highly expressed in the tissues of children with NTDs. circRNA-CDR1as can be used alone or in combination with other markers for routine screening of congenital malformations in early pregnancy, which is of great significance to families and society. The product and method for prenatal screening of neural tube defects can diagnose NTDs by detecting the expression level of circRNA-CDR1as. The detection cost is low, sensitive and fast, and NTDs can be diagnosed in early pregnancy.

Description

technical field [0001] The invention relates to the technical field of clinical diagnosis, in particular to the application of CDR1as in prenatal screening of neural tube defects, products and methods for prenatal screening of neural tube defects. Background technique [0002] Neural tube defects (NTDs) are one of the most common congenital birth defects, which are a series of neural tube defects affecting the brain and spinal cord caused by the failure of the neural tube to close properly in the early embryonic development. The most common NTDs are anencephaly and spinal deformity. Anencephaly usually dies in the womb before birth, resulting in a "stillbirth" or "stillbirth". Even after birth, it will die within a short period of time. Once diagnosed , almost none survived. Those with spinal deformity have severe lifelong disability, which brings huge mental and economic burden to the family. Preventing the occurrence of NTDs through preventive intervention or timely term...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883
CPCC12Q1/6883C12Q2600/158C12Q2600/178Y02A50/30
Inventor 李方成金必莲李军亮许新科陈伟陈程林锦荣袁宏耀李杨潘君平王方宇赵灵凤
Owner GUANGZHOU WOMEN AND CHILDRENS MEDICAL CENTER